Home

Zynex, Inc. - Common Stock (ZYXI)

2.9050
-0.5050 (-14.81%)

Zynex Inc is a medical technology company that specializes in the development and manufacturing of non-invasive medical devices, primarily focused on pain management and rehabilitation

The company's innovative products include electrotherapy devices that utilize neuromuscular electrical stimulation to help patients manage acute and chronic pain, as well as devices designed to aid in physical therapy and recovery. Zynex is committed to improving patient outcomes through its advanced technology and is actively involved in expanding its offerings to meet the growing needs of the healthcare market.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close3.410
Open3.380
Bid2.850
Ask2.910
Day's Range2.770 - 3.500
52 Week Range2.770 - 13.19
Volume1,328,932
Market Cap92.51M
PE Ratio (TTM)32.28
EPS (TTM)0.1
Dividend & YieldN/A (N/A)
1 Month Average Volume312,406

News & Press Releases

Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQZYXI) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · March 13, 2025
Unusual volume stocks in Thursday's sessionchartmill.com
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · March 13, 2025
Zynex, Inc. (ZYXI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQZYXI) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · March 13, 2025
Preview: Zynex's Earningsbenzinga.com
Via Benzinga · October 23, 2024
Why Zynex Plunged Todayfool.com
Earnings and guidance disappointed, but the pullback could be an opportunity.
Via The Motley Fool · July 26, 2024
ZYXI Stock Earnings: Zynex Misses Revenue for Q1 2024investorplace.com
ZYXI stock results show that Zynex missed on revenue for the first quarter of 2024.
Via InvestorPlace · April 30, 2024
Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQZYXI) on behalf of investors concerning the Company’s possible violations of federal securities laws.
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · March 12, 2025
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesdaybenzinga.com
Via Benzinga · March 12, 2025
Building Momentum: Zynex Inc.’s (NASDAQ: ZYXI) Steady Rise in the Pain Management Market
Demand for pain management devices is climbing worldwide, fueled by several major trends. As chronic disease rates soar, the need for effective, drug-free pain solutions has grown more pressing. At the same time, advancements in medical tech have opened doors to safer, non-invasive pain relief options, making them more widely adopted by healthcare providers. Rising numbers of surgeries have also created a strong demand for post-operative pain control, while the pain monitoring market continues to surge. With these combined factors, the global pain management device market is expected to reach $5.68 billion by 2032, expanding at a steady 9% CAGR.
Via AB Newswire · November 8, 2024
Zynex: Q4 Earnings Insightsbenzinga.com
Via Benzinga · February 29, 2024
Earnings Scheduled For March 11, 2025benzinga.com
Via Benzinga · March 11, 2025
Building Momentum: Zynex Inc.’s (NASDAQ: ZYXI) Steady Rise in the Pain Management Market
Building Momentum: Zynex Inc.’s (NASDAQZYXI) Steady Rise in the Pain Management Market
Via News Direct · November 5, 2024
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 26, 2024
COIN Stock: OpenAI Exec Joins Coinbase’s Board of Directorsinvestorplace.com
Coinbase stock is up on Friday after the crypto coin company added OpenAI executive Chris Lehane to its board of directors.
Via InvestorPlace · July 26, 2024
LTM Stock IPO: 7 Things to Know as LATAM Airlines Returns to the NYSEinvestorplace.com
LATAM Airlines stock is back on the NYSE alongside an IPO for LTM shares after they were delisted from the market back in 2020.
Via InvestorPlace · July 26, 2024
Why Is Zynex (ZYXI) Stock Down 24% Today?investorplace.com
Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024.
Via InvestorPlace · July 26, 2024
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Sessiondexcom
Via Benzinga · July 26, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Fridayinvestorplace.com
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!
Via InvestorPlace · July 26, 2024
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · July 26, 2024
ZYXI Stock Earnings: Zynex Misses EPS, Misses Revenue for Q2 2024investorplace.com
ZYXI stock results show that Zynex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 25, 2024
7 Short Squeeze Stocks to Look Into for Your Portfolio
Explore our top picks for short-squeeze stocks that could skyrocket your portfolio. Learn what makes them stand out, and how to spot similar opportunities.
Via MarketBeat · June 27, 2024
3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rallyinvestorplace.com
Although short-squeeze stocks to buy present great risk, betting against the bears can also yield dramatically robust returns.
Via InvestorPlace · June 24, 2024
Analyst Predictions: 3 Stocks Pegged to Soar Over 40% in One Yearinvestorplace.com
Zynex, Hilton Grand and Celsius have at least a 50% upside in the next year, making analysts' list of top stocks to buy for solid gains.
Via InvestorPlace · June 19, 2024
3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation?investorplace.com
Explore industrial stocks that short sellers are targeting, which highlights their challenges and growth prospects amid a volatile market.
Via InvestorPlace · April 2, 2024